Randomized, double‐blind, placebo‐controlled phase 2 study of ganaxolone as add‐on therapy in adults with uncontrolled partial‐onset seizures
Abstract
To evaluate the efficacy and safety of ganaxolone as adjunctive therapy in adults with uncontrolled partial‐onset seizures despite taking up to three concomitant antiepileptic drugs (AEDs).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 23, 2017
- Source ID
- 10.1111/epi.13705
Entities
People
- Julia Tsai
- Michael R Sperling
- Pavel Klein
Organizations
- Defense Advanced Research Projects Agency
- Eisai
- Lundbeck Foundation
- National Institutes of Health
- Thomas Jefferson University